4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Reperfusion Therapy
Reperfusion therapy is a crucial medical intervention designed to restore blood flow to tissues or organs after a period of reduced or blocked circulation, typically observed in conditions such as heart attacks or strokes. The primary goal of reperfusion is to salvage endangered tissue by swiftly re-establishing the oxygen and nutrient supply. This therapeutic approach is often employed in the context of myocardial infarctions, where timely intervention can minimize cardiac damage and improve outcomes. Various reperfusion strategies exist, including the administration of clot-busting medications or the use of catheter-based procedures to reopen blocked vessels. Despite its life-saving potential, the effectiveness of reperfusion therapy hinges on swift diagnosis and prompt implementation, underscoring its critical role in the realm of cardiovascular and neurological care.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Miroslav Radenkovic
University of Belgrade, Serbia
Syed Raza
Awali Hospital, Bahrain
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Characterizing cardiac ECG and echocardiographic abnormalities in cirrhotic patients with and without heart failure
Ishan Abdullah, George Washington University School of Medicine and Health Sciences, United States